The previous chapter discussed the divergent cluster performance in Ohio and Sweden as
perceived by the firms in these clusters. In this chapter we address the same questions from …

As explained in Chapter 1, we have chosen to focus our international comparison mainly on
the area of biomedicine, defined broadly to include pharmaceuticals (not only those based …

We examine the evolution of biotechnology clusters in Germany between 1996 and 2003,
paying particular attention to their composition in terms of venture capital, basic science …

The Stockholm-Uppsala region is claimed to be one of the worlds' most expansive
biomedical regions, both when it concerns scientific and business activities. Or, as it was …

This book presents the results of Cleverbio, a project funded by theEuropean Commission.
The project examined the process of growth anddevelopment of clusters in the biotech …

The present paper is the first preliminary account of a project being planned for 2013,
focussing on the development of the biomedico cluster in North Denmark. The project takes …

This chapter deals with the question raised in Chapter 4—namely,“Why has the biomedical
cluster in Ohio grown faster and become more fully developed than that in Sweden?” By …

Differences in growth patterns between regional clusters are often attributed to the extent to
which they benefit from agglomeration, defined as the advantages that derive from being …

As clusters have developed from an analytical concept into a key policy tool, numerous
cluster initiatives, or collaborative organizations designed to enhance the competitiveness of …

This book presents the results of Cleverbio, a project funded by the European Commission.
The project examined the process of growth and development of clusters in the biotech …